-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA Pharma announced that vamorolone has been selected as a pilot program to accelerate reimbursement for rare disease treatment in South Korea.

Zhitongcaijing·11/06/2026 08:49:13
Listen to the news
NXERA Pharma announced that vamorolone has been selected as a pilot program to accelerate reimbursement for rare disease treatment in South Korea.